SCHEMBL8300301

SCHEMBL8300301

CCN1c2ncccc2C(=O)Nc2c(C)cc(C)nc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.53
CYP2C19 P33261 5/20 0.53
CYP3A4 P08684 4/20 0.53
CYP1A2 P05177 4/20 0.50
CYP2D6 P10635 2/20 0.50
ALDH1A1 P00352 3/20 0.49
POLB P06746 2/20 0.49
LMNA P02545 1/20 0.49
ADORA3 P0DMS8 1/20 0.49
MAPK1 P28482 1/20 0.49
ADORA2A P29274 1/20 0.49
ADORA1 P30542 1/20 0.49
PDE3A Q14432 1/20 0.49
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
MCL1 Q07820 1/20 0.36
CHRM2 P08172 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8887366 0.89 ALDH1A1 (0.48) CYP2C9CYP2C19CYP3A4CYP1A2CYP2D6
SCHEMBL8888835 0.88 ALDH1A1 (0.47) CYP2C9CYP2C19CYP3A4CYP1A2CYP2D6
SCHEMBL8303477 0.88 CYP2C9 (0.58) CYP2C9CYP2C19CYP3A4CYP1A2CYP2D6
SCHEMBL8887469 0.88 ALDH1A1 (0.47) CYP2C9CYP2C19CYP3A4CYP1A2CYP2D6
SCHEMBL8891082 0.88 ALDH1A1 (0.47) CYP2C9CYP2C19CYP3A4CYP1A2CYP2D6
SCHEMBL9004937 0.87 CYP3A4 (0.42) CYP2C9CYP2C19CYP3A4CYP1A2CYP2D6
SCHEMBL8889454 0.86 ALDH1A1 (0.46) CYP2C9CYP2C19CYP3A4CYP1A2CYP2D6
SCHEMBL8302091 0.86 ALDH1A1 (0.46) CYP2C9CYP2C19CYP3A4CYP1A2CYP2D6
SCHEMBL8888695 0.86 ALDH1A1 (0.46) CYP2C9CYP2C19CYP3A4CYP1A2CYP2D6
SCHEMBL8304418 0.86 ALDH1A1 (0.46) CYP2C9CYP2C19CYP3A4CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5620974-A ENZYME INHIBITOR, TREATS ACQUIRED IMMUNE DEFICIENCY SYNDROME(AIDS) BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1997-04-15 US claimed
EP-0429987-A2 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1991-06-05 EP claimed
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 EP disclosed
US-5620974-A ENZYME INHIBITOR, TREATS ACQUIRED IMMUNE DEFICIENCY SYNDROME(AIDS) BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1997-04-15 US disclosed
EP-0498290-B1 Pyridobenzodiazepines, dipyrido [3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1996-09-18 EP disclosed
US-5550117-A HIV-1 REVERSE TRASNCRIPTASE INHIBITOR, USEFUL FOR TREATMENT OF ACQUIRED IMMUNE DIFFICIENCY SYNDROME BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1996-08-27 US disclosed
US-5366972-A 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1994-11-22 US disclosed
EP-0498290-A1 Pyridobenzodiazepines, dipyrido [3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1992-08-12 EP disclosed
EP-0429987-A2 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1991-06-05 EP disclosed